CymaBay Therapeutics Inc (NASDAQ:CBAY)
| 14.90 Delayed Data As of Sep 29 |  -0.67 / -4.30%Today’s Change | 3.16 Today|||52-Week Range 18.20 | +137.64% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 7.7M | 10.5M | 23.1M | 49.0M | |
| Short Term Investment Cash | -3.9M | 2.8M | 12.6M | 25.9M | ||
| Cash & Short Term Investments | 41.5M | 17.0M | 97.2M | 178.7M | ||
| Receivables | Receivables | 186.0K | 0.00 | 5.0M | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 1.1M | 1.4M | 1.2M | 2.6M | |
| Other Current Assets | 0.00 | 165.0K | 126.0K | 304.0K | ||
| Current Assets | 42.8M | 18.5M | 103.5M | 181.6M | ||
| Total Assets | Property, Plant and Equipment - Gross | 321.0K | 363.0K | 390.0K | 3.0M | |
| Depreciation | -257.0K | -286.0K | -321.0K | -130.0K | ||
| Other Assets | 51.0K | 584.0K | 634.0K | 2.3M | ||
| Total Assets | 43.1M | 19.4M | 104.2M | 186.7M | ||
| Liabilities | Accounts Payable | 0.00 | 899.0K | 1.3M | 2.0M | |
| Short Term Debt | 509.0K | 2.7M | 3.1M | 0.00 | ||
| Accrued Expenses | 2.3M | 2.7M | 3.3M | 9.7M | ||
| Other Current Liabilities | 4.6M | 3.9M | 9.5M | 9.7M | ||
| Other Liabilities | 6.1M | 9.3M | 16.3M | 14.4M | ||
| Total Liabilities | Long Term Debt | 8.8M | 6.1M | 3.0M | 0.00 | |
| Other Liabilities | 19.0K | 13.0K | 0.00 | 1.9M | ||
| Total Liabilities | 15.0M | 15.4M | 19.3M | 16.3M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 28.1M | 3.9M | 84.9M | 170.4M | ||
| Total Shareholder Equity | 28.1M | 3.9M | 84.9M | 170.4M | ||
| Share Information | Common Shares Outstanding | 23.4M | 23.4M | 44.4M | 59.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
